10-K Decoder · All companies

Evommune, Inc.

EVMN · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$13.0M$7.00M+85.7%
Operating income−$81.1M−$70.0M−15.8%
Net income−$68.9M−$66.8M−3.1%

Questions

What was Evommune's revenue in FY2025?
$13.0M in FY2025 (Fiscal year ended Dec 31, 2025), +85.7% vs $7.00M a year earlier, per its 10-K filed Mar 2026.
Was Evommune profitable in FY2025?
No: net income was −$68.9M and operating income −$81.1M in FY2025.